Glick, Gary D.
Ifm Therapeutics (United States)
4 papers on CoChatORCID 0000-0003-0959-3749
Most cited papers
- Verified
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery
Inflammasome and immune disordersImmune Response and Inflammation
Cited by 1,885
- Verified
Erratum: Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery
Inflammasome and immune disordersImmune Response and Inflammation
Cited by 465
- Verified
Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease
Gatza, E., Wahl, D. R., Opipari, A. W., Sundberg, T. B., Reddy, P., Liu, C., Glick, G. D., & Ferrara, J. L. M. (2011) · Science Translational Medicine
Cancer, Hypoxia, and MetabolismHematopoietic Stem Cell Transplantation
Cited by 168
- Verified
Anti-DNA autoantibodies and systemic lupus erythematosus
Blatt, N. B., & Glick, G. D. (1999) · Pharmacology & Therapeutics
Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases
Cited by 60
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free